Login
← Go Back
Neuland Laboratories
NEULANDLAB · Pharma > Pharmaceuticals & Drugs · Chairman: Davuluri Rama Mohan Rao · MD: Davuluri Saharsh Rao · Listing date: Oct. 14, 2008 · Employees: 1427 · Hyderabad · http://www.neulandlabs.com
Stock Price vs Company Growth
1d
1.6%
1w
8.0%
1m
16.6%
3m
22.7%
6m
95.3%
1y
270.5%
5y
62.2%
10y
40.6%
all
33.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 7,541 1.6%
5,532
7,794
Company Overview
Sales
1,581 Cr
Growth: 34.0%
Profit after Tax
317 Cr
Growth: 19.1%
Mid Cap
9,675 Cr
P/E: 30.5x
Industry P/E: 35.0x
Fundamentals
Sales (Cr) ₹ 1,581
Growth 34.0%
EBITDA 30.1%
P/S 6.1x
Dividend 0.3%
P/E 30.5x
Book Value ₹ 955
PEG Ratio 0.9x
ROE 28.7%
P/B 7.9x
Shareholding Pattern
Institutions
Malabar India Fund Limited
9.95 %
Malabar Value Fund
4.29 %
Matthews India Fund
2.55 %
Icg Q Limited
1.76 %
Promoters
Ramamohan Rao Davuluri
24.97 %
Davuluri Vijaya Rao
4.78 %
Davuluri Sucheth Rao
2.63 %
Davuluri Saharsh Rao
1.98 %
Davuluri Rohini Niveditha Rao
1.27 %
Others
Mukul Mahavir Agrawal
2.34 %
Kedia Securities Private Limited
1.01 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
Named after Father Nieuwland of Notre dame, Neuland Laboratories was incorporated in 1984 by Dr. D. R. Rao for the manufacture of Salbutamol Sulphate, with mere 40 employees.It has started its commercial production of Salbutamol Sulphate in the year 1986. It has since grown to become one of the most reliable API source for Pharma Industry with addition of more products in course of years.
Belongs to (6 Indices) view more
Investors (89)
icici.pr...
iepf
mukul.ma...
Followers (2)
harit
nilofer4